Allen Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,484
Closed -$509K 209
2017
Q3
$509K Sell
2,484
-505
-17% -$117K 0.02% 147
2017
Q2
$727K Buy
+2,989
New +$702K 0.03% 130
2016
Q3
Sell
-3,541
Closed -$818K 228
2016
Q2
$818K Sell
3,541
-27,432
-89% -$6.32M 0.06% 99
2016
Q1
$8.3M Buy
30,973
+13,917
+82% +$3.98M 0.65% 31
2015
Q4
$5.33M Sell
17,056
-651
-4% -$194K 0.45% 37
2015
Q3
$4.81M Sell
17,707
-762
-4% -$234K 0.46% 39
2015
Q2
$5.61M Sell
18,469
-30,309
-62% -$9.04M 0.53% 34
2015
Q1
$14.5M Buy
48,778
+47,470
+3,629% +$13.5M 1.06% 38
2014
Q4
$337K Sell
1,308
-53,692
-98% -$13.4M 0.03% 177
2014
Q3
$13.3M Buy
+55,000
New +$12.3M 1.1% 35

Other funds holding AGN

Allen Investment Management's AGN Position: Q4 2017 in Review

Allen Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 2,484 shares — an estimated $509K sold.

Allen Investment Management first reported a position in AGN in Q3 2014 and held it in 10 quarters. The position peaked at $14.5M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Allen Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Allen Investment Management sold 2,484 Allergan plc shares in Q4 2017, an estimated $509K.
  • Allen Investment Management first reported a position in Allergan plc in Q3 2014 and held it in 10 quarters.
  • Allen Investment Management's Allergan plc position peaked at $14.5M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Allen Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.